Park Place Capital’s Genmab GMAB Stock Holding History

Park Place Capital’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.47K	Hold	90	–	–	﹤0.01%	991
2026 Q1	$2.42K	Hold	90	–	–	﹤0.01%	742
2025 Q4	$2.77K	Sell	90 -66	-42%	-$2.06K	﹤0.01%	688
2025 Q3	$4.79K	Hold	156	–	–	﹤0.01%	651
2025 Q2	$3.23K	Hold	156	–	–	﹤0.01%	693
2025 Q1	$3.05K	Hold	156	–	–	﹤0.01%	700
2024 Q4	$3.26K	Hold	156	–	–	﹤0.01%	688
2024 Q3	$3.8K	Sell	156 -2,697	-95%	-$72.1K	﹤0.01%	718
2024 Q2	$71.7K	Sell	2,853 -2,361	-45%	-$66.9K	0.02%	324
2024 Q1	$156K	Buy	5,214 +323	+7%	+$9.49K	0.06%	261
2023 Q4	$156K	Buy	4,891 +535	+12%	+$16.8K	0.06%	251
2023 Q3	$154K	Buy	4,356 +75	+2%	+$2.86K	0.05%	275
2023 Q2	$163K	Sell	4,281 -371	-8%	-$14.8K	0.05%	277
2023 Q1	$176K	Sell	4,652 -264	-5%	-$10.1K	0.05%	261
2022 Q4	$208K	Buy	+4,916	New	+$203K	0.06%	239

Other funds holding GMAB

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Park Place Capital's GMAB Position: Q2 2026 in Review

Park Place Capital held its Genmab (GMAB) position steady in Q2 2026 at 90 shares worth $2.47K. The position accounts for ﹤0.01% of the portfolio, ranked #991.

Park Place Capital first reported a position in GMAB in Q4 2022 and has held it in 15 quarters since. The position peaked at $208K in Q4 2022. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

Park Place Capital held 90 shares of Genmab worth $2.47K as of Q2 2026.
Park Place Capital left its Genmab share count unchanged in Q2 2026.
Genmab made up ﹤0.01% of Park Place Capital's portfolio in Q2 2026, its #991 holding.
Park Place Capital first reported a position in Genmab in Q4 2022 and has held it in 15 quarters since.
Park Place Capital's Genmab position peaked at $208K in Q4 2022.
289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.